Navigation Links
InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
Date:3/20/2009

em," said Steven Inchcoombe, Managing Director, Nature Publishing Group. "Through this partnership with InnoCentive, Nature Publishing Group hopes to explore how we can help increase the chance of solving these global problems. We look forward to working with InnoCentive to promote the expertise of scientists and bring benefits to the wider community."

This agreement comes at a pivotal time when businesses, especially those in life sciences, are endeavoring to maintain research and development activities with reduced budgets and resources. The partnership of NPG and InnoCentive will accelerate the uptake of open innovation as a complementary business model that has particular appeal during a global economic downturn.

"Nature is one of the most well-known scientific publications on the market and this partnership boosts awareness of the benefits of open innovation within the scientific community," said Dwayne Spradlin, CEO of InnoCentive, Inc. "It is imperative for companies to engage in open innovation for many reasons, including cost savings and improving lead times to development. Nature Publishing Group has been a pioneer in their use of Web 2.0 tools to interact with their community. We look forward to working with them."

Further details will be announced in due course.

About Nature Publishing Group (NPG):

Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, and a range of prestigious academic journals including society-owned publications. NPG also provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs.

In recent years, NPG has develo
'/>"/>

SOURCE InnoCentive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Brain Signature for Cigarette Cravings Identified
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. InVitrias Cellastim Showcased in Nature Article
7. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
11. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:7/10/2014)... 2014 Parker Waichman LLP, a ... of victims injured by defective medical devices, reports ... allegations that the woman’s hidden, aggressive leiomyosarcoma was ... used during a routine laparoscopic supracervical hysterectomy procedure. ... Medical Instruments Corporation over its Wolf Power Morcellator ...
(Date:7/10/2014)... record becomes widespread across the United States, due in ... the quantity of clinical data that will become available ... Additionally, experts in healthcare have become increasingly focused ... for the purpose of gleaning insights that have the ... a process that is known as big data. ...
(Date:7/10/2014)... with dyslexia are more likely to report that they ... who don,t have the learning disorder, according to a ... 10 percent of people, causes problems with reading and ... this condition said they suffered physical abuse during their ... "Even after accounting for age, race, sex and ...
(Date:7/10/2014)... July 10, 2014 (HealthDay News) -- Men who have ... prostate cancer, a new study suggests. But the ... urologists not involved with the study said more research ... truly accurate. For the study, Harvard researchers analyzed ... followed for 24 years, starting in 1986. During that ...
(Date:7/10/2014)... 10, 2014In response to today,s announcement that the "Mississippi ... has now been found to have detectable levels of ... expresses disappointment in this setback but remains hopeful that ... to remain undetectable for more than two years will ... and ultimately develop a cure. , "Although we ...
Breaking Medicine News(10 mins):Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2
... donations is spiraling for older couples wanting to start ... ... shifts in parenting,trends have fertility experts at Reproductive Endocrinology Associates of,Charlotte (REACH) ... 2008 -- including new outreach through the Internet --,in efforts to stem ...
... Patent Expands Geographic Coverage, IRVING, ... (OTC Bulletin Board: CARN) today announced ... patent application No. 200600484, titled,"Delivery of ... Anionic,Polysaccharides," relating to the Company,s proprietary ...
... Professor of Epidemiology and Associate Dean for Health Promotion ... of Medicine, and Virginia A. Stallings, MD, PhD, the ... Penn and Professor of Pediatrics at The Childrens Hospital ... a special public session, Understanding Obesity and Childhood at ...
... Nationally in, March 2008 Tells the Story of Six ... Mountain in the Himalayas with Blind Climber ... Entertainment and Junior,Blind of America announced today that from ... (opening March,2008) will travel to the United States for ...
... the Way to Educating Children With Food,Allergies, FAIRFAX, ... (FAAN) is proud to announce the release of two ... allergies.,Alexander, the Elephant Who Couldn,t Eat Peanuts ... Goes ... ... Gets a Babysitter help,children cope with their own ...
... Progress in Women,s Cancer, Theme, Spotlights Four ... Cancers, CHICAGO, Feb. 11 The Society ... Meeting on Women,s Cancer March,9-12 at the Tampa ... will feature more than 350 scientific presentations,lectures, workshops, ...
Cached Medicine News:Health News:Charlotte IVF Experts Issue Urgent Call for Egg Donors, Eye New Recruiting Tools 2Health News:Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office 2Health News:Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office 3Health News:Blind Tibetan Teenagers Featured in Award-Winning Film, 'Blindsight,' Unite with Students from Junior Blind of America to Share Life Experiences 2Health News:Blind Tibetan Teenagers Featured in Award-Winning Film, 'Blindsight,' Unite with Students from Junior Blind of America to Share Life Experiences 3Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 2Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 3Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 2Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 3
... Every Bard BrachyStar® Needle is designed ... an efficient and clinically effective brachytherapy procedure. ... featuring ultra-sharp tips and polished surfaces for ... of needle configurations and sizes assures an ...
... The BrachySource iodine-125 implant is a combination ... remarkable visibility that makes BrachySource I-125 implant ... You can be confident that every BrachySource ... seed management services which is required by ...
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
... Used for temporary internal drainage from the ... of a stricture. The segment with no ... lumen while preventing ingrowth of the ureteral ... peel-open packages. Intended for one-time use. CAUTION: ...
Medicine Products: